sohm has a revenue Year to Date 3rd Qtr 2018 of 397,688 and is on track to make what they said back on December 7, 2017
SOHM, Inc., Announces $0.5m Purchase Order for a range of Pharmaceutical products in 2018.
CHINO HILLS, CA—December 7, 2017 – SOHM, Inc. (PINKSHEETS: SHMN) is a globally-known generic pharmaceutical manufacturer, developer and marketer of a wide range of products serving a broad segment of the therapeutics market.
SOHM has received a purchase order, with an initial order of more than $0.5 million to supply a range of pharmaceutical products to one of its east coast customers, that will run through the end of 2018.
This new purchase order comes from a current customer that has executed purchase orders with SOHM through the end of 2017.
A spokesperson for SOHM, Inc., said, “SOHM is very pleased to have received this order from this customer that supplies retail and pharmacy networks all across the United States. This represents an annualized commitment to purchase and distribute 6 products other than SOHM products while providing SOHM a lucrative base to the huge American market for Generic Pharmaceuticals.
SOHM’s spokesperson said completion of this order would assure that SOHM achieves its target for higher revenue growth in 2018 compared to previous years.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India as well as strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Forward-Looking Statements
This press release contains many forward-looking statements such as “project,” “plan,” “can,” etc. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
714-522-6700
source
https://www.sohm.com/2017/12/07/sohm-inc-anno...s-in-2018/
SOHM, Inc., Announces $0.5m Purchase Order for a range of Pharmaceutical products in 2018.
CHINO HILLS, CA—December 7, 2017 – SOHM, Inc. (PINKSHEETS: SHMN) is a globally-known generic pharmaceutical manufacturer, developer and marketer of a wide range of products serving a broad segment of the therapeutics market.
SOHM has received a purchase order, with an initial order of more than $0.5 million to supply a range of pharmaceutical products to one of its east coast customers, that will run through the end of 2018.
This new purchase order comes from a current customer that has executed purchase orders with SOHM through the end of 2017.
A spokesperson for SOHM, Inc., said, “SOHM is very pleased to have received this order from this customer that supplies retail and pharmacy networks all across the United States. This represents an annualized commitment to purchase and distribute 6 products other than SOHM products while providing SOHM a lucrative base to the huge American market for Generic Pharmaceuticals.
SOHM’s spokesperson said completion of this order would assure that SOHM achieves its target for higher revenue growth in 2018 compared to previous years.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India as well as strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Forward-Looking Statements
This press release contains many forward-looking statements such as “project,” “plan,” “can,” etc. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
714-522-6700
source
https://www.sohm.com/2017/12/07/sohm-inc-anno...s-in-2018/
